Welcome to Weight loss

Weight Loss Prescription Drugs

weight loss prescription drugs

The Latest Today


weight loss prescription drugs

weight loss prescription drugs

Sales and prescriptions of a weight-loss drug were suspended yesterday after European health authorities said the benefits no longer outweighed the risks. The European Medicines Agency said obese people taking Acomplia were roughly twice as likely to ...

Read more


Obesity drug withdrawn over depression link - Guardian Unlimited

The market for weight-loss drugs in Europe changed dramatically yesterday as Sanofi-Aventis was forced to withdraw Acomplia, its anti-obesity drug, from sale, while GlaxoSmithKline (GSK) gained approval for another. Sanofi was ordered temporarily to ...

Read more


Sanofi-Aventis forced to withdraw slimming drug in Europe - Times Online

According to health experts, Frederic J. Vagnini, M.D. and Selene Yeager, authors of ’30 Minutes a Day to a Healthy Heart’, the human body naturally contains millions of fat cells. Fat droplets called lipids contain the flexible mass of every ...

Read more


Body Fats - Mindanao Times

We could all do with a little less spam in our lives. With that in mind, all of us gained ground last week when authorities from the U.S. and New Zealand successfully shut down one of the world’s largest perpetrators of spam. It was no small ...

Read more


Putting spam in its place - Edwardsville Intelligencer

As the obesity crisis worsens and more pharmaceutical companies are hoping to improve their bottom line by shrinking their customers' bottoms. After all, we are a short-cut society (who wouldn't rather pop a pill than engage in the hard work of ...

Read more


The Diet-Pill Dilemma - Time

Oct. 24 (Bloomberg) -- The failure of Sanofi-Aventis SA 's Acomplia weight-loss pill threatens the development of new medicines to fight obesity. The suspension of Acomplia sales yesterday in Europe struck a knockout blow to the most promising drug ...

Read more


Sanofi's Acomplia Failure Threatens Obesity Drug Development - Bloomberg

The United States can probably kiss goodbye to the arrival of Sanofi-Aventis' anti-obesity rimonabant (Acomplia). The European Medicines Agency, which assesses the safety of drugs after they have been released, has recommended that marketing ...

Read more


Bad news for anti-obesity drug Acomplia * - Los Angeles Times Blogs

Rimonabant, also known as Acomplia, was hailed as a wonder drug that would help obese people lose weight and stopped the urge to smoke when it was launched in 2006. The European drugs regulator has recommended suspending its licence after new ...

Read more


Obesity drug linked to suicides taken off the market - Daily Telegraph

Merck, the pharmaceuticals giant, has announced 7,200 job losses, bringing the number of redundancies at the industry's ten largest companies to more than 60,000, as evidence emerges that the global economic crisis is affecting spending on medicines ...

Read more


Merck loses 7,200 jobs as credit crisis leads to cutbacks in medical ... - Times Online

Oct. 23 (Bloomberg) -- Sanofi-Aventis SA 's once-promising obesity drug Acomplia suffered a knockout blow as European regulators recommended pulling it from the market because of side effects including suicide and depression. Obese or overweight ...

Read more


Top Now


weight loss prescription drugs